4 Recruiting Solid Tumors Phase 3 Clinical Trials
Active phase 3 studies for solid tumors enrolling across the USA. Verify eligibility and contact site coordinators.
All Solid Tumors studiesPhase 3 Studies for Solid Tumors
🔵 Active, Not Recruiting Phase3
A Safety and Efficacy Extension Study of Pertuzumab in Patients With Solid Tumors Previously Enrolled in a Hoffmann-La Roche-Sponsored Pertuzumab Clinical Trial
📍 Santa Casa de Misericordia de Porto Alegre — Porto Alegre, Rio Grande do Sul
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
Avelumab Program Rollover Study
📍 HonorHealth Research Institute — Scottsdale, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
📍 Investigative Site US058 — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase3
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
📍 Arizona Cancer Center at UMC North ( Site 0018) — Tucson, Arizona
View Study & Checklist ➔